Acute Myelogenous Leukemia
8 competing products in clinical development for Acute Myelogenous Leukemia.
Pipeline by Phase
Phase 12
Phase 24
Phase 2/31
Approved1
All Products (8)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| micafungin + posaconazole | Astellas Pharma | Approved | Completed | 43 |
| Decitabine | Eisai | Phase 2/3 | Completed | 38 |
| Decitabine | Eisai | Phase 2 | Completed | 35 |
| Decitabine + Gemtuzumab ozogamicin | Eisai | Phase 2 | Completed | 35 |
| Ondansetron + Palonosetron | Eisai | Phase 2 | Completed | 35 |
| Bisantrene | Race Oncology | Phase 2 | Completed | 29 |
| Milademetan + AZA + Milademetan | Daiichi Sankyo | Phase 1 | Terminated | 21 |
| KW-2449 | Kyowa Kirin | Phase 1 | Terminated | 21 |